×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Astigmatism Market

ID: MRFR/MED/18332-HCR
100 Pages
Garvit Vyas
February 2026

US Astigmatism Market Research Report By Type (Myopic Astigmatism, Hyperopic Astigmatism, others), By Treatment (Corrective Lenses, Orthokeratology (Ortho-K), Surgeries, others) and By End User (Hospital, Clinics, others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Astigmatism Market Infographic
Purchase Options

US Astigmatism Market Summary

As per analysis, the US Astigmatism Market is projected to grow from USD 415 Million in 2024 to USD 877 Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.04% during the forecast period (2025 - 2035).

Key Market Trends & Highlights

The US Astigmatism Market is experiencing a transformative shift towards personalized and technologically advanced solutions.

  • Rising awareness of eye health is driving demand for astigmatism correction solutions.
  • Corrective lenses remain the largest segment, while surgical procedures are the fastest-growing segment in the market.
  • Hospitals dominate the market, yet eye care centers are emerging as the fastest-growing providers of astigmatism treatments.
  • The increasing prevalence of astigmatism and advancements in vision correction technologies are key market drivers.

Market Size & Forecast

2024 Market Size 0.415 (USD Million)
2035 Market Size 0.877 (USD Million)
CAGR (2025 - 2035) 7.04%

Major Players

Johnson & Johnson (US), Bausch + Lomb (US), Alcon (US), CooperVision (US), EssilorLuxottica (US), Carl Zeiss (US), Hoya Corporation (US), Ray-Ban (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

US Astigmatism Market Trends

The US Astigmatism Market is currently experiencing notable developments, driven by an increasing awareness of eye health and advancements in corrective technologies. As more individuals recognize the impact of astigmatism on vision quality, there is a growing demand for effective treatment options. This trend is further supported by educational initiatives aimed at informing the public about the condition and its implications. Additionally, the market is witnessing a shift towards personalized treatment plans, as healthcare providers increasingly tailor solutions to meet individual patient needs. This customization enhances patient satisfaction and outcomes, potentially leading to higher adoption rates of corrective lenses and surgical interventions. Moreover, the integration of innovative technologies in the US Astigmatism Market is reshaping the landscape of vision correction. The emergence of advanced diagnostic tools and surgical techniques is facilitating more accurate assessments and effective treatments. As a result, patients are likely to benefit from improved precision in their corrective options. Furthermore, the collaboration between healthcare professionals and technology developers appears to be fostering a more comprehensive approach to managing astigmatism, which may enhance overall patient care. The combination of heightened awareness, personalized treatment, and technological advancements suggests a promising trajectory for the US Astigmatism Market in the near future.

Rising Awareness of Eye Health

There is a noticeable increase in public awareness regarding eye health, particularly concerning astigmatism. Educational campaigns and outreach programs are effectively informing individuals about the condition, its symptoms, and available treatment options. This heightened awareness is likely to drive more people to seek professional evaluations and corrective measures.

Personalized Treatment Approaches

Healthcare providers in the US Astigmatism Market are increasingly adopting personalized treatment strategies. By tailoring solutions to individual patient needs, practitioners can enhance the effectiveness of corrective measures. This trend may lead to improved patient satisfaction and better visual outcomes.

Technological Advancements in Vision Correction

The US Astigmatism Market is witnessing significant technological innovations that are transforming vision correction methods. Advanced diagnostic tools and surgical techniques are becoming more prevalent, allowing for more precise assessments and effective treatments. This evolution in technology is likely to improve patient experiences and outcomes.

US Astigmatism Market Drivers

Increasing Prevalence of Astigmatism

The US Astigmatism Market is experiencing growth due to the rising prevalence of astigmatism among the population. Recent data indicates that approximately 28.3 percent of the US population suffers from some form of astigmatism, which translates to millions of individuals requiring corrective measures. This increasing prevalence is likely to drive demand for various treatment options, including glasses, contact lenses, and surgical interventions. As awareness of eye health continues to grow, more individuals are seeking solutions for their vision problems, thereby expanding the market. Furthermore, the aging population, which is more susceptible to refractive errors, contributes to this trend. The combination of these factors suggests a robust growth trajectory for the US Astigmatism Market in the coming years.

Increased Focus on Preventive Eye Care

The US Astigmatism Market is benefiting from a growing emphasis on preventive eye care. Public health campaigns and educational initiatives are raising awareness about the importance of regular eye examinations and early detection of vision problems. This proactive approach encourages individuals to seek professional help before their astigmatism worsens, leading to a higher demand for corrective measures. Additionally, insurance policies are increasingly covering routine eye exams, making it more accessible for the population to receive necessary care. As more people prioritize their eye health, the US Astigmatism Market is expected to see a surge in demand for various treatment options, including corrective lenses and surgical procedures.

Advancements in Vision Correction Technologies

Technological innovations are playing a pivotal role in shaping the US Astigmatism Market. The introduction of advanced laser technologies, such as LASIK and PRK, has revolutionized the way astigmatism is treated. These procedures offer patients quicker recovery times and improved visual outcomes compared to traditional methods. Moreover, the development of toric contact lenses specifically designed for astigmatism has enhanced the options available for patients. According to industry reports, the market for toric lenses is projected to grow significantly, reflecting the increasing demand for specialized vision correction solutions. As these technologies continue to evolve, they are likely to attract more patients seeking effective treatments, thereby bolstering the US Astigmatism Market.

Regulatory Support for Vision Health Initiatives

The US Astigmatism Market is positively influenced by regulatory support for vision health initiatives. Government policies aimed at improving eye care access and affordability are fostering a conducive environment for market growth. Programs that promote regular eye screenings and subsidize treatment costs are encouraging more individuals to seek help for astigmatism. Furthermore, collaborations between public health organizations and private sectors are enhancing the availability of innovative treatments. As these initiatives gain traction, they are likely to expand the reach of the US Astigmatism Market, ensuring that more patients receive the care they need.

Growing Demand for Personalized Eye Care Solutions

The US Astigmatism Market is witnessing a shift towards personalized eye care solutions. Patients are increasingly seeking tailored treatments that address their specific vision needs. This trend is driven by advancements in diagnostic tools that allow for more accurate assessments of astigmatism. Customized contact lenses and surgical options are becoming more prevalent, catering to individual preferences and lifestyles. The rise of telemedicine has also facilitated access to specialized eye care, enabling patients to receive consultations and follow-ups from the comfort of their homes. As the demand for personalized solutions continues to rise, the US Astigmatism Market is likely to expand, offering a wider array of options for consumers.

Market Segment Insights

By Application: Corrective Lenses (Largest) vs. Surgical Procedures (Fastest-Growing)

In the US Astigmatism Market, the application segment is primarily divided into four categories: Corrective Lenses, Surgical Procedures, Diagnostic Devices, and Vision Therapy. Corrective Lenses initially dominate the market, capturing a significant portion of the share due to their widespread accessibility and familiarity among consumers. However, surgical procedures are gaining momentum, slowly reshaping the competitive landscape as more patients turn to surgical options for long-term solutions to vision correction.

Corrective Lenses (Dominant) vs. Surgical Procedures (Emerging)

Corrective Lenses represent the dominant force within the US Astigmatism Market, catering to a large consumer base that values easy-to-use solutions for vision correction. They are available in various types, including glasses and contact lenses, characterized by affordability and availability. Meanwhile, Surgical Procedures are emerging as a preferred alternative, driven by technological advancements and a growing number of outpatient surgical options available. This segment is witnessing rapid growth, particularly due to increased consumer awareness, patient referrals, and favorable outcomes associated with surgical interventions, which contribute to its appeal over time.

By End Use: Hospitals (Largest) vs. Eye Care Centers (Fastest-Growing)

In the US Astigmatism Market, the distribution of market share among various end-use segments highlights that hospitals represent the largest share, owing to their expansive facilities and advanced technological resources. Optometry clinics and eye care centers also play critical roles, but hospitals remain the primary choice for patients seeking comprehensive eye care services due to their established reputation and access to specialist doctors. Home care also contributes significantly, catering to patients preferring convenience and comfort at home, though it lags behind the institutional settings. Growth trends in the US Astigmatism Market show a promising shift towards eye care centers, which are becoming the fastest-growing segment due to an increasing focus on specialized care. Factors such as the rising prevalence of astigmatism, growing awareness among the aging population, and the expansion of service offerings in eye care centers contribute to this upward trajectory. Additionally, innovations in treatment options and patient management approaches are driving more patients to seek care in these specialized environments rather than traditional hospital settings.

Hospitals (Dominant) vs. Home Care (Emerging)

Hospitals remain a dominant force in the US Astigmatism Market, primarily due to their comprehensive capabilities and extensive resources. They possess the capacity to handle complex conditions and provide advanced surgical interventions, a critical advantage in treating astigmatism effectively. On the other hand, home care represents an emerging segment, driven by patient preference for convenience and personalized care. While hospitals cater to a wide array of astigmatism issues with their established treatment protocols, home care focuses on offering manageable, non-invasive solutions for patients who desire treatment within the comfort of their homes. Both segments have unique strengths, with hospitals leading in innovation and capability, whereas home care is gaining traction due to adaptability to patient needs.

By Type of Astigmatism: Regular Astigmatism (Largest) vs. Irregular Astigmatism (Fastest-Growing)

In the US Astigmatism Market, Regular Astigmatism holds the largest market share, accounting for a significant portion of the overall segment distribution. With its straightforward characteristics and well-established treatment options, it remains the most recognized type among patients. On the other hand, Irregular Astigmatism is gaining momentum, driven by the increasing awareness and advancements in customized corrective solutions, positioning it as a key player in the market.

Regular Astigmatism (Dominant) vs. Irregular Astigmatism (Emerging)

Regular Astigmatism is characterized by its more predictable refractive error, making it easier to diagnose and treat with standard corrective lenses or surgeries. This segment's dominance can be attributed to its widespread prevalence and familiarity within the healthcare system. In contrast, Irregular Astigmatism presents a more complex challenge due to its unpredictable nature; it often results from conditions like keratoconus and necessitates specialized corrective measures such as rigid gas permeable contact lenses. With the market's focus shifting towards personalized treatment solutions, Irregular Astigmatism is poised for significant growth, appealing to a more diverse patient base seeking advanced optical therapies.

By Age Group: Adults (Largest) vs. Children (Fastest-Growing)

In the US Astigmatism Market, the age group segment is characterized by a significant distribution among three primary categories: Children, Adults, and the Elderly. Adults hold the largest market share, driven by the prevalence of astigmatism in working-age populations who are increasingly aware of eye health. Children, while a smaller segment, are witnessing a swift rise in astigmatism diagnoses, reflecting a broader trend of increased screenings and early detection. Meanwhile, the elderly representation continues to be substantial due to natural age-related vision changes. Growth trends indicate an increasing awareness of astigmatism in children, encouraged by educational initiatives and health campaigns promoting routine eye examinations. Advances in technology have made corrective options more accessible and attractive to both adults and children. The broader adaptation of digital devices also contributes to the rise in astigmatism cases among all age groups, prompting a growing demand for tailored optical solutions that cater to distinct visual requirements across age demographics.

Adults (Dominant) vs. Children (Emerging)

The segment comparison reveals that Adults are the dominant force within the US Astigmatism Market, driven by high levels of engagement in workplace settings where visual clarity is essential. Adults often seek out corrective lenses and treatments to manage their astigmatism effectively, contributing to substantial market stability. In contrast, Children represent an emerging segment, with growing attention from parents and healthcare providers toward early diagnosis and intervention. This demographic exhibits unique needs in their vision care, driving demand for specialized corrected eyewear that ensures comfort and functionality. The marketing dynamics around this emerging group increasingly focus on educational initiatives emphasizing the necessity of eye health from a young age, paving the way for innovative solutions that are tailored specifically for children.

Get more detailed insights about US Astigmatism Market

Key Players and Competitive Insights

The Astigmatism Market in the US is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on customer-centric solutions. Key players such as Johnson & Johnson (US), Bausch + Lomb (US), and Alcon (US) are actively pursuing strategies that emphasize technological advancements and product differentiation. For instance, Johnson & Johnson (US) has been focusing on enhancing its product portfolio through the integration of advanced digital technologies, which appears to be a response to the growing demand for personalized vision correction solutions. This collective emphasis on innovation among major players is likely to intensify competition and drive market growth.

In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure of the market is moderately fragmented, with several key players exerting significant influence. This fragmentation allows for a diverse range of products and services, catering to various consumer needs while fostering a dynamic competitive environment.

In December 2025, Bausch + Lomb (US) announced the launch of a new line of toric contact lenses specifically designed for astigmatism, which is expected to enhance visual acuity for users. This strategic move not only reinforces Bausch + Lomb's commitment to innovation but also positions the company to capture a larger share of the growing astigmatism segment. The introduction of these lenses is likely to resonate well with consumers seeking effective solutions for their vision correction needs.

In November 2025, Alcon (US) unveiled a new digital platform aimed at improving patient engagement and education regarding astigmatism treatment options. This initiative reflects Alcon's strategic focus on digital transformation, which is becoming increasingly vital in the healthcare sector. By enhancing patient access to information, Alcon is likely to strengthen its brand loyalty and improve patient outcomes, thereby solidifying its competitive position in the market.

In October 2025, CooperVision (US) entered into a strategic partnership with a leading telehealth provider to offer virtual consultations for patients with astigmatism. This collaboration is indicative of a broader trend towards integrating telehealth solutions within the optical industry. By facilitating easier access to eye care professionals, CooperVision is not only enhancing its service offerings but also addressing the growing consumer preference for convenience in healthcare.

As of January 2026, the Astigmatism Market is witnessing trends that emphasize digitalization, sustainability, and the integration of artificial intelligence (AI) in product development and customer engagement. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and enhancing service delivery. Moving forward, it appears that competitive differentiation will increasingly hinge on technological advancements and supply chain reliability, rather than solely on price. This shift suggests a potential evolution in market dynamics, where companies that prioritize innovation and customer-centric solutions may emerge as leaders in the Astigmatism Market.

Key Companies in the US Astigmatism Market include

Industry Developments

Recent developments in the US Astigmatism Market have highlighted significant advancements and shifts among key players. For example, in October 2023, Alcon announced a breakthrough in its lens technology aimed at enhancing vision for those with astigmatism, showcasing ongoing innovation in the field. In September 2023, CooperVision launched a new line of toric contact lenses designed specifically for astigmatism, further solidifying their commitment to addressing this condition. Additionally, EssilorLuxottica reported growth in its product offerings targeting astigmatism, which supported a rise in their market valuation during Q3 2023.

Mergers and acquisitions continue to shape this market, with Santen Pharmaceutical acquiring a US-based technology company focused on developing astigmatism correction devices in August 2023. This acquisition is expected to bolster Santen’s presence in the US market.

The influence of these companies, along with regulatory support for advanced eye care technologies, has positioned the US astigmatism market for substantial growth. Major players like Bausch and Lomb, Hoya Corporation, and Johnson and Johnson are also evolving their strategies to meet the increasing demand for innovative solutions in astigmatism correction.

Future Outlook

US Astigmatism Market Future Outlook

The US Astigmatism Market is projected to grow at a 7.04% CAGR from 2025 to 2035, driven by technological advancements, increasing awareness, and rising prevalence of astigmatism.

New opportunities lie in:

  • Development of advanced toric contact lenses for astigmatism correction.
  • Expansion of telemedicine platforms for remote eye examinations.
  • Investment in AI-driven diagnostic tools for personalized treatment plans.

By 2035, the market is expected to achieve substantial growth, reflecting evolving consumer needs and technological innovations.

Market Segmentation

US Astigmatism Market End Use Outlook

  • Hospitals
  • Optometry Clinics
  • Eye Care Centers
  • Home Care

US Astigmatism Market Age Group Outlook

  • Children
  • Adults
  • Elderly

US Astigmatism Market Application Outlook

  • Corrective Lenses
  • Surgical Procedures
  • Diagnostic Devices
  • Vision Therapy

US Astigmatism Market Type of Astigmatism Outlook

  • Regular Astigmatism
  • Irregular Astigmatism
  • Mixed Astigmatism

Report Scope

MARKET SIZE 20240.415(USD Million)
MARKET SIZE 20250.452(USD Million)
MARKET SIZE 20350.877(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)7.04% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledJohnson & Johnson (US), Bausch + Lomb (US), Alcon (US), CooperVision (US), EssilorLuxottica (US), Carl Zeiss (US), Hoya Corporation (US), Ray-Ban (US)
Segments CoveredApplication, End Use, Type of Astigmatism, Age Group
Key Market OpportunitiesAdvancements in digital eye care technology enhance patient access and treatment options in the US Astigmatism Market.
Key Market DynamicsRising demand for advanced corrective lenses drives innovation and competition in the US Astigmatism Market.
Countries CoveredUS
Leave a Comment

FAQs

What is the current valuation of the US Astigmatism Market?

The US Astigmatism Market was valued at 0.415 USD Million in 2024.

What is the projected market valuation for the US Astigmatism Market in 2035?

The market is projected to reach a valuation of 0.877 USD Million by 2035.

What is the expected CAGR for the US Astigmatism Market during the forecast period?

The expected CAGR for the US Astigmatism Market from 2025 to 2035 is 7.04%.

Which companies are the key players in the US Astigmatism Market?

Key players include Johnson & Johnson, Bausch + Lomb, Alcon, CooperVision, EssilorLuxottica, Carl Zeiss, Hoya Corporation, and Ray-Ban.

What are the main applications in the US Astigmatism Market?

Main applications include Corrective Lenses, Surgical Procedures, Diagnostic Devices, and Vision Therapy.

How do the valuations of corrective lenses compare to surgical procedures in the market?

Corrective Lenses had a valuation range of 0.166 to 0.366 USD Million, while Surgical Procedures ranged from 0.125 to 0.275 USD Million.

What are the primary end-use segments in the US Astigmatism Market?

Primary end-use segments include Hospitals, Optometry Clinics, Eye Care Centers, and Home Care.

What is the market valuation for adults suffering from astigmatism?

The market valuation for adults is projected to range from 0.207 to 0.446 USD Million.

How does the market for irregular astigmatism compare to regular astigmatism?

The market for Irregular Astigmatism is projected to range from 0.149 to 0.308 USD Million, compared to Regular Astigmatism's range of 0.166 to 0.366 USD Million.

What age groups are primarily affected by astigmatism in the US?

The primary age groups affected include Children, Adults, and the Elderly, with valuations ranging from 0.083 to 0.179 USD Million, 0.207 to 0.446 USD Million, and 0.125 to 0.252 USD Million, respectively.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions